Delta Sleep-Inducing Peptide Protects Liver from Chronic Stress in Rats
Background
The liver is highly susceptible to damage from various stressors, including psychological stress, which can induce oxidative stress and impair hepatocyte function. Understanding how to mitigate this damage is crucial for maintaining liver health. This study specifically investigates the protective effects of Delta Sleep-Inducing Peptide (DSIP) on liver cells during both acute and chronic restraint stress.
Study Design
Results
Under conditions of acute restraint stress, 40 μg/kg DSIP led to a complex response, increasing both antioxidant enzyme activities (catalase and superoxide dismutase, SOD) and malonic dialdehyde (MDA) concentration, a marker of oxidative damage. However, the effects were markedly different and more protective under chronic stress. In chronic stress, 40 μg/kg DSIP demonstrated the most pronounced protective effect, significantly decreasing catalase and SOD activities, and notably reducing MDA concentration, indicating reduced oxidative stress. At a dose of 120 μg/kg DSIP during chronic stress, rats showed a decrease in SOD activity and MDA concentration, an increase in total protein content, and a reduction in AST activity, suggesting improved liver function. Interestingly, increasing the dose to 360 μg/kg DSIP completely abolished these beneficial effects, highlighting a dose-dependent response.
Why It Matters
This research highlights the hepatoprotective potential of Delta Sleep-Inducing Peptide (DSIP), particularly in mitigating liver damage caused by chronic psychological stress. The findings suggest that DSIP could be a promising candidate for developing therapies to protect the liver in individuals experiencing prolonged stress or stress-related conditions. Further research, including human trials, could explore DSIP's clinical utility in preventing or treating stress-induced liver dysfunction.